MichaelVernerisMD

PubMed

• Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
  Jennifer W Cao, Renata Impastato, Lyndah Chow, Luisanny Perez, Laura Chubb, Jade Kurihara, Steven Dow, Jessica Lake, Michael R Verneris> ;Cancer Immunology, Immunotherapy. 2024 Mar 30
• Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium fo...
  Adams, C., Michlitsch, J., Chen, K., Hossain, M., Davis, A., Park, J., Gardner, R., Keller, M., Aguayo-Hiraldo, P., Verneris, M.> ;Transplantation and Cellular Therapy. 2024 Mar 4
• A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and ...
  Al Malki, M. M., Ryotaro Nakamura, Corinna La Rosa, Dongyun Yang, Joshua A Hill, Armin Rashidi, Hannah Choe, Qiao Zhou, Chetan Raj Lingaraju, Teodora Kaltcheva, Jeffre...> ;Haematologica. 2024 Feb 8
• Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-...
  Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy ...> ;Eclinicalmedicine. 2023 Nov 1
• Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic ...
  Amy Moskop, Lena E Winestone, Christina Baggott, Julie-An Talano, Deborah Schiff, Jenna Rossoff, Arunkumar Modi, Michael R Verneris, Theodore W Laetsch, Liora Schultz,...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• 1 citations
  HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
  Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J Chen, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine Phili...> ;Blood Advances. 2023 Jun 27
• 1 citations
  Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?
  Laura McLaughlin, Edwin DeZoeten, Michael R Verneris> ;British Journal of Haematology. 2023 Mar 1
• 19 citations
  Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
  Heather E Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R Verneris, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Julie-An Talano, Amy Mosko...> ;Blood Advances. 2023 Feb 28
• 47 citations
  Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
  Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
• 22 citations
  Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
  Liora M Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K Keating, Christa Krupski, Holly Pacenta, Christine L Philips, Julie-An Talano, Amy ...> ;Journal of Clinical Oncology. 2023 Jan 10
• 6 citations
  Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment.
  Joselyn Cruz Cruz, Kristen C Allison, Lauren S Page, Alexis J Jenkins, Xiaodong Wang, H Shelton Earp, Stephen V Frye, Douglas K Graham, Michael R Verneris, Alisa B Lee...> ;Frontiers in Immunology. 2023 Jan 1
• Time to transplantation and pediatric acute myeloid leukemia outcomes.
  Lindsey A Murphy, Kristen Miller, Amanda C Winters, Anna R K Franklin, Michael R Verneris, Amy K Keating> ;Bone Marrow Transplantation. 2023 Mar 1
• 6 citations
  Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
  Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W Le...> ;Blood Advances. 2022 Sep 13
• 19 citations
  Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
  Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Jenna Rossoff, Heather E Stefanski, Julie-An Talano, Steve P Margo...> ;Blood Advances. 2022 Jul 26
• 1 citations
  SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium.
  Seon-Hui Shim, Dejene Tufa, Renee Woods, Trahan D George, Tyler Shank, Ashley Yingst, Jessica Lake, Laura Cobb, Dallas Jones, Kenneth Jones, Michael R Verneris> ;Stem Cells Translational Medicine. 2022 May 27
• 65 citations
  Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen R...
  Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Jenna Rossoff, Heather E Stefanski, Julie-An Talano, Amy Moskop, Steven P Mar...> ;Journal of Clinical Oncology. 2022 Mar 20
• 28 citations
  Tisagenlecleucel Outcomes in Relapsed/Refractory Extramedullary ALL: A Pediatric Real World CAR Consortium Report.
  Vanessa A Fabrizio, Christine L Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly L Pacenta, Jenna Rossoff, Heather E. Ste...> ;Blood Advances. 2021 Nov 18
• 37 citations
  Optimal fludarabine lymphodepletion is associated with improved outcomes following CAR T-cell Therapy.
  Vanessa A Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly L Pacenta, Christine L Phillips, Jenna ...> ;Blood Advances. 2021 Nov 17
• 5 citations
  Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia.
  Michael R. Verneris, Qiufei Ma, Jie Zhang, Amy K. Keating, Ranjan Tiwari, Junlong Li, Hongbo Yang, Abhijit Agarwal, Lida Bubuteishvili Pacaud> ;Blood Advances. 2021 Oct 1
• 4 citations
  Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
  Jenna Rossoff, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michae...> ;Blood. 2021 Nov 25
• 17 citations
  Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.
  John E. Wagner, Karen K. Ballen, Mei-Jie Zhang, Mariam Allbee-Johnson, Chatchada Karanes, Filippo Milano, Michael R. Verneris, Mary Eapen, Claudio G. Brunstein> ;Blood Advances. 2021 Oct 26
• 2 citations
  Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Dono...
  Hemalatha G. Rangarajan, Marcelo S.F. Pereira, Ruta Brazauskas, Andrew St. Martin, Ashleigh Kussman, Ezgi Elmas, Michael R. Verneris, Shahinaz M. Gadalla, Steven G.E. ...> ;Transplantation and Cellular Therapy. 2021 Nov 1
• 28 citations
  Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
  John E. Levine, Stephan A. Grupp, Michael A. Pulsipher, Andrew C. Dietz, Susana Rives, G. Douglas Myers, Keith J. August, Michael R. Verneris, Jochen Buechner, Theodor...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 57 citations
  Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
  Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca A. Marsh, Lauri Burroughs, Navneet S. Majhail, A. Samer Al-Homsi, Zaid ...> ;Transplantation and Cellular Therapy. 2021 Aug 1
• Neither Donor nor Recipient Mitochondrial Haplotypes Are Associated with Unrelated Donor Transplant Outcomes: A Validation Study from the CIBMTR
  Logan G. Spector, Stephen R. Spellman, Bharat Thyagarajan, Kenneth B. Beckman, Cody Hoffmann, John R. Garbe, Theresa Hahn, Lara E. Sucheston-Campbell, Michaela Richard...> ;Transplantation and Cellular Therapy. 2021 Jun 23
• Join now to see all

Journal Articles

• The Effect of NIMA Matching in Adult Unrelated Mismatched Hematopoietic Stem Cell Transplantation – a Joint Study of the Acute Leukemia Working Party of the EBMT and t...  
  Tao Wang, Michael R Verneris, Katharine C Hsu, Nature
• Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic Leukemia  
  John E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
• A Validation Study Failed to Confirm Association between Genetic Variants in the Base Excision Repair Pathway and TRM and Relapse post HCT  
  Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Weihua G, Haagenson M, Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan B, Biol Blood Marrow Transplant, 1/25/2016
• Metabolic Syndrome After Hematopoietic Cell Transplantation:At the Intersection of Treatment Toxicity and Immune Dysfunction  
  Turcotte L, Yingst A, Verneris MR, Biol Blood Marrow Transplant, 1/21/2016
• Loss of T Follicular Helper Cells In the Peripheral Blood Of Patients With Chronic Graft vs Host Disease  
  Knorr DA, Wang H, Aurora M, Macmillan ML, Holtan SG, Bergerson R, Cao Q, Weisdorf DJ, Cooley S, Brunstein C, Miller JS, Wagner JE, Blazar BR, Verneris MR, Biol Blood Marrow Transplant, 1/13/2016
• Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD  
  He F, Warlick E, Miller JS, MacMillan M, Verneris MR, Cao Q, Weisdorf D, Biol Blood Marrow Transplant, 1/11/2016
• IL-15 Trispecific Killer Engagers (TriKEs) Make NK Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function  
  Vallera DA, Felices M, McElmurry RT, McCullar V, Zhou X, Schmohl J, Zhang B, Lenvik A, Panoskaltsis-Mortari A, Verneris MR, Tolar J, Cooley S, Weisdorf D, Blazar BR, M..., Clin Cancer Research, 1/4/2016
• Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation  
  Brunstein CG, Petersdorf EW, DeFor TE, Noreen H, Maurer D, MacMillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE, Biol Blood Marrow Transplant, 1/30/2015
• Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: effect of radiation dose and conditioning regimen  
  Wilke C, Holtan SG, Sharkey L, DeFor T, Arora M, Premakanthan P, Yohe S, Vagge S, Zhou D, Holter Chakrabarty JL, Mahe M, Corvo R, Dusenbery K, Storme G, Weisdorf DJ, V..., Radiother Oncol, 1/30/2015
• Transplant Outcomes for Children with T-Cell Acute Lymphoblastic Leukemia in Second Remission: A Report of the CIBMTR®  
  Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Guilcher ..., Biol Blood Marrow Transplant, 1/28/2015
• Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow Transplant  
  Turcotte LM and Verneris MR, Clin Cancer Res, 1/19/2015
• Phase 1 study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies  
  Bachanova V, Frankel AE, Cao Q, Lewis D, Grzywacz B, Verneris MR, Ustun C, Lazaryan A, McClune B, Warlick ED, Kantarjian H, Weisdorf DJ, Miller JS, Vallera DA, Clin Cancer Res, 1/15/2015
• Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation  
  Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Muller C, Battiwalla M, Gajewski J, Verneris MR, Ringden O, Marino S..., Biol Blood Marrow Transplant, 1/8/2015
• HLA Mismatch Is Associated With Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for...  
  Verneris MR, Lee SJ, Ahn KW, Wang HL, Battiwalla M, Inamoto Y, Fernandez-Vina MA, Gajewski J, Pidala J, Munker R, Aljurf M, Saber W, Spellman S, Koreth J, Biol Blood Marrow Transplant, 1/6/2015
• Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure  
  Lund TC, Liegel J, Bejanyan N, Orchard PJ, Cao Q, Tolar J, Brunstein C, Wagner JE, Verneris MR, Weisdorf D, Am J Hematol, 1/6/2015
• Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation  
  Ahn YO, Weeres MA, Neulen ML, Choi J, Kang SH, Heo DS, Bergerson R, Blazar BR, Miller JS, Verneris MR, Eur J Immunol, 1/5/2015
• Impact of long-term cryopreservation on single umbilical cord blood transplant outcomes  
  Mitchell R, Wagner JE, Brunstein CG, Cao Q, McKenna DH, Lund TC, Verneris MR, Biol Blood Marrow Transplant, 1/1/2015
• An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation (HCT) outcomes  
  Ross JA, Tolar J, Spector LG, DeFor T, Lund TC, Weisdorf DJ, Langer E, Hooten AJ, Thyagarajan B, Gleason MK, Wagner JE, Robien K, Verneris MR, Biol Blood Marrow Transplant, 1/1/2015
• Multi-institutional Feasibility Study of a Fast Patient Localization Method in Total Marrow Irradiation With Helical Tomotherapy: A Global Health Initiative by the Int...  
  Takahashi Y, Vagge S, Agostinelli S, Han E, Matulewicz L, Schubert K, Chityala R, Ratanatharathorn V, Tournel K, Penagaricano JA, Florian S, Mahe MA, Verneris MR, Weis..., Int J Radiat Oncol Biol Phys, 1/1/2015
• Circulating Angiogenic Factors Associated with Response and Survival after Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802  
  Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisd..., Biol Blood Marrow Transplant, 1/1/2015
• Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer  
  Davis ZB, Felices M, Verneris MR, Miller JS, Cancer J, 1/1/2015
• One-unit versus two-unit cord-blood transplantation for hematologic cancers Blood and Marrow Transplant Clinical Trials Network  
  Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, N Engl J Med, 1/30/2014
• KIR B or not to be? that is the question for ALL  
  Verneris MR, Miller JS, Blood, 1/23/2014
• Clearance of acute myeloid leukemia by haploidentical natural killer cells improved using IL-2 diphtheria toxin fusion protein  
  Bachanova V, Cooley S, Defor TE, Verneris MR, Zhang B, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lewis D, Hippen K, McGlave P, Weisdorf DJ, Blazar BR, Miller JS, Blood, 1/19/2014
• CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets  
  Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Lenvik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ..., Blood, 1/8/2014
• Join now to see all

Books/Book Chapters

• Advances and Controversies in Hematopoietic Cell Transplants and Cell Therapy 
  Chapter: Cord Blood Transplants for Myeloid Malignancies in Children 
  Dietz AC, Verneris MRSpringer Publishing2016
• Umbilical Cord Blood Banking and Transplantation for Stem Cell Biology and Regenerative Medicine 
  Chapter: Cord Blood Transplantation for Pediatric Hematologic Malignancies: Indications, Mechanisms, and Outcomes 
  Stefanski HE and Verneris MREditors: Karen Ballen.Springer Publishing2014
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Natural Killer Cells and Allogeneic Hematopoietic Cell Transplantation 
  Verneris MR and Miller JSEditors: F.R. Appelbaum, S.J. Forman, R.S. Negrin & K.G. Blume.Blackwell PublishingEdition 4th,2009
• Clinical Bone Marrow and Stem Cell Transplantation 
  Chapter: NK-T Cells Biology and Clinical Applications 
  Verneris MR, Negrin RSEditors: Atkinson, Fibbe, Chaplin, Ljungman, Ritz and Brenner.Cambridge University PressEdition 3rd,2002
• Allogeneic Stem Cell Transplantation 
  Chapter: Allogeneic Effector Cell Populations: Separating GVL From GVHD 
  Verneris MR, Negrin RSEditors: Lazarus HM, Laughlin MJ.Humana Press Inc., Totowa, NJ2001
• Natural Killer Cells 
  Chapter: Development of NK Cells from Hematopoietic Precursors and Developmental Steps in NK Cell Maturation 
  Grzywacz B, Miller JS, Verneris MREditors: Michael T. Lotze and Angus W. Thompson.Academic Press
• Cord Blood Biology, Transplantation, Banking, and Regulatory Considerations 
  Chapter: Cord Blood NK Cells 
  Yong-Oon A and Verneris MREditors: Hal Broxmeyer.AABB Press
• Hematology: Basic Principles and Practice 
  Chapter: NK Cell-Based Therapies 
  Cooley S, Verneris MR, Miller JSEditors: Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop H.Churchill Livingstone ElsevierEdition 6th,
• Thomas' Hematopoietic Cell Transplantation 
  Verneris MR and Miller JSBlackwell PublishingEdition 5th,
• Join now to see all

Abstracts/Posters

• Romiplostim Improves Platelet Recovery after UCB Transplant
  Michael R Verneris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Pre- Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
  Trottier B, Miller H, Cao Q, Miller JS, Verneris MR, Weisdorf DJ, Levine J, Burns LJ, BMT Tandem Meetings, San Diego, CA, 1/11/2015
• Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
  Phelan R, Mann E, Napurski C, Defor TE, Petryk A, Miller WP, Wagner JE, Verneris MR, Smith AR, BMT Tandem Meetings, San Diego, CA, 1/11/2015
• Second Allogeneic Hematopoietic Cell Transplantation For Graft Failure: Poor Outcomes for Neutropenic Graft Failure.
  Lund TC, Liegel J, Benjanyan N, Orchard PJ, Cao Q, Tolar J, Brunstein C, Wagner JE, Verneris MR, Weisdorf D, BMT Tandem Meetings, San Diego, CA, 1/11/2015
• Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802.
  Holtan S, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, Defor TE, MacMillan ML, Cooley S, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ, BMT Tandem Meetings, San Diego, CA, 1/11/2015
• Prevention of Acute GVHD by Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg).
  Brunstein C, Hippen K, DeFor TE, Curtsinger J, Sumstad D, Levine BL, June CH, Miller JS, Verneris MR, Blazar BR, Wagner JE, BMT Tandem Meetings, San Diego, CA, 1/11/2015
• Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT).
  Abu Shanap MS, Cooley S, Luo X, Qing C, Curtsinger J, Bergerson R, Bejanyan N, Stefanski H, Brunstein C, DJ, Blazar BR, Miller JS, Wagner JE, Verneris MR, 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• First-in-human' phase I dose escalation trial of IL-15N72D/IL-15Ralpha-Fc superagonist complex (ALT-803) demonstrates immune activation with anti-tumor activity in pat...
  Miller JS, Cooley S, Holtan SG, Arora M, Ustun C, Jeng E, Wong HC, Verneris MR, Wagner JE, Weisdorf DJ, Blazar BR, Fehniger TA, Romee R, 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• Antigen Level Matching at HLA-C Improves Long-Term Outcomes after Double Umbilical Cord Blood Transplantation.
  Brunstein CG, Cutler CS, DeFor TE, Spitzer TR, Bejanyan N, Garfall AL, Verneris MR, Chen Y, Warlick E, Kim HT, Miller JS, Antin JH, Weisdorf DJ, Soiffer RJ, Wagner JE,..., 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes.
  Madbouly A, Wang T, Albrecht M, Paunic V, Haagenson MD, Vierra-Green C, Fleischhauer K, Hsu KC, Verneris MR, Majhail NS, Lee SJ, Spellman SR, Maiers M, 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• Similar Survival after Umbilical Cord Blood (UCB) and HLA-Matched Adult Donor Transplantation by Disease Risk Index (DRI) Assignment.
  Bejanyan N, Brunstein CG, Cao Q, Lazaryan A, Warlick ED, Ustun C, Holtan SG, Arora M, Bachanova V, Verneris MR, Wagner JE, Weisdorf DJ, 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion.
  Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion., 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• A Phase I Study of Intravenous NCI IL-15 to Enhance Adoptively Transferred NK Cells Uncovers Defects in CD16 Triggered IFNgamma Production and Competition Between Dono...
  Miller JS, Verneris MR, Curtsinger J, DeFor TE, McKenna D, Waldmann TA, Blazar BR, Weisdorf DJ, Cooley S, 57th ASH Annual Meeting & Exposition, Orlando, FL, 1/5/2015
• The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation.
  Kornblit B, Wang T, Lee SJ, Spellman SR, Zhu X, Fleischhauer, K, Müller C, Verneris MR, Johansen JS, Vindelov L, Garred P, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study.
  Lazaryan A, Wang T, Spellman, SR, Wang HL, Muller CR, Fernandez-Vina MA, Verneris MR, Arora M, Weisdorf DJ, Horowitz MM, Lee SJ, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Stem Cell Source Dependent Differences in Reconstituting Peripheral T Follicular Helper Cells Following Hematopoietic Cell Transplantation, Their Association with Chro...
  Knorr DA, Nelson RW, Shanley R, Karras N, Miller JS, Wagner JE, Blazar BR, Verneris MR, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation.
  Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Panoskaltsis-Mortari A, Weisdorf DJ, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Relationship of Epidermal Growth Factor to Cyclosporine- Assocated Magnesium Wasting and Clinical Outcomes Post-Allogeneic Hematopoietic Cell Transplantation.
  He FC, Verneris MR, Cooley SA, Blazar BR, MacMillan ML, Panoskaltsis-Mortari A, Weisdorf DJ, Holtan SG, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Acute Graft Versus Host Disease after Donor Lymphocyte Infusion: A Single Center Analysis.
  He FC, Weisdorf DJ, Warlick ED, Miller JS, Holtan SG, Verneris MR, Cao Q, MacMillan ML, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT).
  Ross JA, Tolar J, Spector LG, DeFor T, Lund TC, Weisdorf DJ, Langer E, Hooten AJ, Thyagarajan B, Gleason MK, Wagner JE, Robien K, Verneris MR, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Tr...
  Cichocki F, Davis ZB, DeFor TE, Cooley SA, Bryceson YT, Diamond DJ, Blazar BR, Brunstein C, Wagner JE, Verneris MR, Weisdorf DJ, Miller JS, 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Clonal Expansion of Adaptive NK Cells and NKG2C+CD57+ KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and ...
  Davis ZB, Frank Cichocki F, Felices M, Wangen R, DeFor TE,Cooley SA, Bryceson YT, Diamond DJ, Brunstein C, Blazar BR, Wagner JE, Weisdorf DJ, Horowitz A, Guethlein LA,..., 56th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/6/2014
• Similar Survival in Patients with Acute Myeloid Leukemia Relapsing After Matched Related Donor and Umbilical Cord Blood Transplantation.
  Bejanyan N, Oran B, Shanley R, Ustun C, Warlick E, Verneris MR, Wagner JE, Weisdorf DJ, Brunstein CG, BMT Tandem Meetings, Salt Lake City, UT, 1/13/2013
• Death Receptor 3 (DR3) Is Expressed by Innate Lymphoid Cells 3 (ILC3) and Acts as Costimulatory Receptor.
  Verneris MR, Ahn YO, Weeres MA, Blazar BR, Miller JS, 55th Annual Meeting of the American Society of Hematology, New Orleans, LA, 1/7/2013
• Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival.
  Stefanski HE, Burke MJ, Cao Q, Smith AR, MacMillan ML, Warlick ED, Weisdorf DJ, Wagner JE, Verneris MR, 55th Annual Meeting of the American Society of Hematology, New Orleans, LA, 1/7/2013
• Join now to see all

Lectures

• "Adoptive Therapy with Innate Lymphoid Cells" 
  Minneapolis, MN - 1/28/2015
• "Immunotherapy Research in Pediatric Cancer" 
  Minneapolis, MN - 1/24/2015
• "Total Marrow Irradiation: The UMN Experience" 
  Marie Curie Institute, Paris, France - 1/22/2015
• "Harnessing the Immune System for Cancer Therapy" 
  Morgantown, WV - 1/22/2015
• "NK Cells and Other Innate Lymphoid Cells in Cancer & BMT" 
  Cincinnati, OH - 1/17/2015
• "Two Faces of a Killer: Natural Killer Cells and Innate Lymphoid Cells In Cancer and BMT" 
  Philadelphia, PA - 1/15/2015
• "PROP 1412-20 Impact of donor obesity and inflammation on acute and chronic GVHD among HCT recipients" 
  San Diego, CA - 1/11/2015
• "Cellular immunotherapy for leukemia: From CARs to BiKes and TriKes" 
  Bangalore, India - 1/7/2015
• "Two Faces of a Killer: The Generation of Natural Killer and Innate Lymphoid Cells from Hematopoietic Stem Cells" 
  1/30/2014
• "Two faces of a Killer: Natural Killer Cells and Innate Lymphoid Cells" 
  Houston, TX - 1/18/2014
• "Public Cord Blood Banking" 
  St. Louis, MO - 1/10/2014
• "NK sub population proliferation and serum cytokine levels" 
  San Francisco, CA - 1/5/2014
• "Future of Stem Cell Transplantation" 
  Dallas, TX - 1/18/2013
• "Hematopoietic Stem Cell Transplantation in HIV" 
  Minneapolis, MN - 1/17/2013
• "Therapeutic use of NK Cells Derived from Hematopoietic Stem Cell" 
  Nijmegen, Netherlands - 1/16/2013
• "The Two Faces of the Killer: NK Cells in Leukemia and Immune Reconstitution" 
  Montreal, Canada - 1/8/2013
• "Oral Session Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: NK Cell Biology" 
  New Orleans, LA - 1/7/2013
• "Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Cord Blood Transplantation" 
  San Francisco, CA - 1/6/2013
• "The Two Faces of the Killer: NK Cells in Leukemia and Immune Reconstitution Hematopoietic Stem Cell Transplantation for Acute Leukemia" 
  Sioux Falls, SD - 1/3/2013
• "Graft vs. Leukemia in Acute Lymphoblastic Leukemia: Overview of The Biology" 
  Minneapolis, MN - 1/28/2012
• "Pediatric Cord Blood Transplantation" 
  1/25/2011
• "What We Think We Know About Double Cord Transplantation" 
  San Francisco, CA - 1/24/2011
• "Cord Blood, Bone Marrow and Hematopoietic Progenitor Cell, Apheresis: A Comparison" 
  1/16/2011
• "NK cells and Cancer Therapy" 
  Minneapolis, MN - 1/16/2011
• "Umbilical Cord Blood in Adults: Results and Future Directions" 
  Turin, Italy - 1/12/2011
• Join now to see all

Other

• Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL. 
  Verneris MR, Hematology AM Soc Hematol Educ Program
  1/1/2013